Literature DB >> 36186231

Surgical removal of giant pelvic liposarcoma after preoperative transcatheter arterial embolization.

Yuto Maeda1, Yuji Miyamoto1, Yukiharu Hiyoshi1, Kojiro Eto1, Masaaki Iwatsuki1, Shiro Iwagami1, Yoshifumi Baba1, Naoya Yoshida1, Hideo Baba1.   

Abstract

Liposarcoma includes tumors with a wide range of malignancies, from mostly benign to malignant. We report a case of a 73 year-old man who was admitted for urination and defecation disorder. Contract computed tomography (CT) revealed a mass of approximately 21 cm occupying the pelvis, bladder, ureter, prostate, and rectum being compressed by the tumor. Since intraoperative mass bleeding was predicted, we embolized the tumor nutrition artery and performed a total pelvic exenteration. Regarding the course of the operation, SSI and pelvic infection were developed after the operation. The patient was discharged 21 days after surgery. Moreover, there is no evidence of local recurrence and distant metastasis at 18 months after surgery. Furthermore, in giant pelvic liposarcoma, it is useful to identify a nutritional artery of a giant tumor by angiography before surgery, and surgical resection can be safely done by performing preoperative transcatheter arterial embolization.
© The Author(s) under exclusive licence to The Japan Society of Clinical Oncology 2022.

Entities:  

Keywords:  Pelvic liposarcoma; Total pelvic exenteration; Transcatheter arterial embolization

Year:  2022        PMID: 36186231      PMCID: PMC9522956          DOI: 10.1007/s13691-022-00560-z

Source DB:  PubMed          Journal:  Int Cancer Conf J        ISSN: 2192-3183


  20 in total

1.  Does preoperative transarterial embolization decrease blood loss during spine tumor surgery?

Authors:  Zhihong Qiao; Ningyang Jia; Qian He
Journal:  Interv Neuroradiol       Date:  2015-02       Impact factor: 1.610

Review 2.  Bleeding in cancer patients and its treatment: a review.

Authors:  Candice Johnstone; Shayna E Rich
Journal:  Ann Palliat Med       Date:  2017-12-18

3.  Outcome of total pelvic exenteration for primary rectal cancer.

Authors:  Hideyuki Ike; Hiroshi Shimada; Shigeki Yamaguchi; Yasushi Ichikawa; Shouichi Fujii; Shigeo Ohki
Journal:  Dis Colon Rectum       Date:  2003-04       Impact factor: 4.585

4.  Transarterial chemoembolization for management of hemoptysis: initial experience in advanced primary lung cancer patients.

Authors:  Akihiko Seki; Chigusa Shimono
Journal:  Jpn J Radiol       Date:  2017-06-12       Impact factor: 2.374

5.  Intraoperative bleeding and haemostasis during pelvic surgery for locally advanced or recurrent rectal cancer: a prospective evaluation.

Authors:  V A Bonello; A Bhangu; J E F Fitzgerald; S Rasheed; P Tekkis
Journal:  Tech Coloproctol       Date:  2014-06-03       Impact factor: 3.781

6.  Omental flap after pelvic exenteration for pelvic cancer.

Authors:  Yuji Miyamoto; Takahiko Akiyama; Yasuo Sakamoto; Ryuma Tokunaga; Mayuko Ohuchi; Hironobu Shigaki; Junji Kurashige; Masaaki Iwatsuki; Yoshifumi Baba; Naoya Yoshida; Hideo Baba
Journal:  Surg Today       Date:  2016-05-25       Impact factor: 2.549

7.  Retrospective review of pelvic malignancies undergoing total pelvic exenteration.

Authors:  Maureen P Kuhrt; Ravi J Chokshi; David Arrese; Edward W Martin
Journal:  World J Surg Oncol       Date:  2012-06-15       Impact factor: 2.754

8.  Myxoid liposarcoma in a 91-year-old patient.

Authors:  Brandon S Sheffield; Torsten O Nielsen
Journal:  Mol Cytogenet       Date:  2013-11-19       Impact factor: 2.009

9.  Preoperative rectal tumor embolization as an adjunctive tool for bloodless abdominoperineal excision: A case report.

Authors:  Marley Ribeiro Feitosa; Lucas Fernandes de Freitas; Antonio Balestrim Filho; Guilherme Seizem Nakiri; Daniel Giansante Abud; Ligia Magnani Landell; Mariângela Ottoboni Brunaldi; Jose Joaquim Ribeiro da Rocha; Omar Feres; Rogério Serafim Parra
Journal:  World J Clin Oncol       Date:  2020-12-24

Review 10.  Clinical application of interventional embolization in tumor-associated hemorrhage.

Authors:  Yi Chen; Yi Yang; Wen-Ji Xu; Yu-Jing Xin; Ya-Nan Wang; Xiang Zhou; Xiao Li
Journal:  Ann Transl Med       Date:  2020-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.